ImmunityBio Files 8-K with Financial Updates
Ticker: IBRX · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001326110
| Field | Detail |
|---|---|
| Company | Immunitybio, Inc. (IBRX) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k, sec-filing
Related Tickers: IBIO
TL;DR
IBIO dropped an 8-K on 4/9/26 with financial results. Check it out.
AI Summary
ImmunityBio, Inc. filed an 8-K on April 9, 2026, reporting its financial results and condition. The filing includes exhibits such as financial statements and a company logo. The company's mailing and business address is 3530 John Hopkins Court, San Diego, CA 92121.
Why It Matters
This filing provides investors with crucial, up-to-date information on ImmunityBio's financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and exhibits, not indicating any immediate operational or financial distress.
Key Players & Entities
- ImmunityBio, Inc. (company) — Filer of the 8-K report
- 0001326110 (company) — CIK number for ImmunityBio, Inc.
- 2026-04-09 (date) — Filing date and period of report
- 3530 John Hopkins Court, San Diego, CA 92121 (location) — Mailing and business address for ImmunityBio, Inc.
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates Item 2.02: Results of Operations and Financial Condition, but the specific details of the results are not provided in the summary text.
What are the included exhibits with this 8-K filing?
The filing lists EX-99.1 (likely financial statements) and a company logo (IMMUNITYBIO LOGO) as exhibits.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-09 at 07:39:06.
What is the CIK number for ImmunityBio, Inc.?
The CIK number for ImmunityBio, Inc. is 0001326110.
What is the business and mailing address for ImmunityBio, Inc.?
The business and mailing address for ImmunityBio, Inc. is 3530 John Hopkins Court, San Diego, CA 92121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding ImmunityBio, Inc. (IBRX).